Weksler N, Ovadia L
Department of Anesthesiology, Hillel Yaffe Medical Center, Hadera, Israel.
J Clin Anesth. 1991 Nov-Dec;3(6):442-6. doi: 10.1016/0952-8180(91)90090-a.
To examine the efficacy of a nasal continuous positive airway pressure (CPAP) system for respiratory support in patients who have respiratory insufficiency but are able to maintain spontaneous breathing without hypercapnia, respiratory acidosis, or deteriorated mental status.
Prospective study.
Medical and surgical patients admitted to the intensive care unit (ICU) at the Hillel Yaffe Medical Center.
Nineteen patients with acute respiratory insufficiency and intact mental status who were able to maintain spontaneous breathing without hypercapnia or respiratory acidosis. Additional entry criteria were as follows: arterial oxygen tension (PaO2) less than 65 mmHg on inspired oxygen tension (FIO2) greater than or equal to 0.45, PaO2/FIO2 less than 150, respiratory rate greater than 35 breaths/minute, and inability to tolerate mask CPAP.
Nasal CPAP (10 cmH2O) was applied to patients through two nasopharyngeal airways with an internal diameter (ID) of 8 mm each, inserted in both nostrils. During CPAP application, the patients were requested to breathe through their nose with their mouth closed. Even if they breathed through their open mouth, however, CPAP was maintained despite an observed pressure decrease of 4 cmH2O.
All patients showed a constant improvement in arterial blood gases, PaO2/FIO2, and respiratory signs during nasal CPAP of 10 cmH2O. PaO2 increased from 52 +/- 5.3 mmHg to 131 +/- 20 mmHg with CPAP administration (p less than 0.05), while arterial carbon dioxide tension (PaCO2) increased from 32 +/- 2 mmHg to 36 +/- 2 mmHg (p less than 0.05) and respiratory rate decreased from 39 +/- 2.3 breaths/minute to 31 +/- 1.6 breaths/minute (p less than 0.05).
Nasal CPAP (10 cmH2O) is a reliable alternative to support arterial oxygenation in patients with respiratory failure who are alert and vigorous enough to avoid hypercapnia and respiratory acidosis while breathing spontaneously. In addition, since the patients are able to speak and thus are capable of expressing their feelings, the anxiety observed during respiratory support can be reduced.
探讨鼻持续气道正压通气(CPAP)系统对呼吸功能不全但能自主呼吸且无高碳酸血症、呼吸性酸中毒或精神状态恶化患者的呼吸支持效果。
前瞻性研究。
希勒尔·雅法医疗中心重症监护病房(ICU)收治的内科和外科患者。
19例急性呼吸功能不全且精神状态正常、能自主呼吸且无高碳酸血症或呼吸性酸中毒的患者。其他入选标准如下:吸入氧浓度(FIO2)≥0.45时动脉血氧分压(PaO2)低于65 mmHg,PaO2/FIO2低于150,呼吸频率大于35次/分钟,且无法耐受面罩CPAP。
通过两个内径均为8 mm的鼻咽气道对患者应用鼻CPAP(10 cmH2O),分别插入双侧鼻孔。在应用CPAP期间,要求患者闭嘴经鼻呼吸。然而,即便患者经口呼吸,尽管观察到压力下降4 cmH2O,仍维持CPAP。
所有患者在10 cmH2O鼻CPAP治疗期间动脉血气、PaO2/FIO2和呼吸体征均持续改善。应用CPAP时,PaO2从52±5.3 mmHg升至131±20 mmHg(p<0.05),而动脉血二氧化碳分压(PaCO2)从32±2 mmHg升至36±2 mmHg(p<0.05),呼吸频率从39±2.3次/分钟降至31±1.6次/分钟(p<0.05)。
鼻CPAP(10 cmH2O)是一种可靠的替代方法,可以为呼吸衰竭且意识清醒、活力充足、能自主呼吸以避免高碳酸血症和呼吸性酸中毒的患者提供动脉氧合支持。此外,由于患者能够说话并表达自己的感受,因此可以减轻呼吸支持期间观察到的焦虑情绪。